Allylamine and β-aminopropionitrile induced aortic medial necrosis: Mechanisms of synergism

Toxicology

Volumn 125, Issue 2-3, 1998, Pages 107-115

  Kumar, D ^a   Trent, M B ^a   Boor, P J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aminopropionitrile; Allylamine; Aortic smooth muscle; L Cysteine; Phenelzine; Semicarbazide; Vascular media

Indexed keywords

3 AMINOPROPIONITRILE; ALLYLAMINE;

ANIMAL EXPERIMENT; AORTA MEDIA; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; MALE; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING; VASCULAR SMOOTH MUSCLE;

ALLYLAMINE; AMINOPROPIONITRILE; ANALYSIS OF VARIANCE; ANIMALS; AORTA; BODY WEIGHT; DIET; DRUG SYNERGISM; MALE; MUSCLE, SMOOTH, VASCULAR; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE;

EID: 0032489064     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00168-6     Document Type: Article

References (27)

1. Awasthi S., Boor P.J. Allylamine and β-aminopropionitrile-induced vascular injury: enhanced expression of high-molecular-weight proteins. J. Toxicol. Env. Health. 52:1997;101-116.
2. Barrow M.V., Simpson C.F., Miller E.J. Lathyrism: a review. Q. Rev. Biol. 49:1974;101-128.
3. Biagini R.E., Toraason M.A., Lynch D.W., Winston G.W. Inhibition of rat heart mitochondrial electron transport in vitro: implications for the cardiotoxic action of allylamine or its primary metabolite, acrolein. Toxicology. 62:1990;95-106.
4. Boor P.J. Allylamine cardiovascular toxicity: V. Tissue distribution and toxicokinetics after oral administration. Toxicology. 35:1985;167-177.
5. Boor P.J., Nelson T.J. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase. Toxicology. 18:1980;87-102.
6. Boor P.J., Nelson T.J. Biotransformation of the cardiovascular toxin, allylamine, by rat and human cardiovascular tissue. J. Mol. Cell. Cardiol. 14:1982;679-682.
7. Boor, P.J., Langford, S.D., 1997. Pathogenesis of arterial lesions caused by chemicals. In: Sipes, I.G., McQueen, C.A., Gandolfi, A.J. (Eds.), Cardiovascular Toxicology. Elsevier Science, Oxford, pp. 333-368.
8. Boor P.J., Moslen M.T., Reynolds E.S. Allylamine cardiotoxicity: I. Sequence of pathologic events. Toxicol. Appl. Pharmacol. 50:1979;581-592.
9. Boor P.J., Hysmith R.M., Sanduja R. A role for a new vascular enzyme in the metabolism of xenobiotic amines. Circ. Res. 66:1990;249-252.
10. Craven J.L. The characterization of lathyrism in the experimental animal. Arch. Pathol. 89:1970;160-163.
11. Hysmith R.M., Boor P.J. Allylamine cardiovascular toxicity: VI. Subcellular distribution in rat aortas. Toxicology. 35:1985;179-187.
12. Hysmith R.M., Boor P.J. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells. Toxicology. 51:1988;133-145.
13. Kumar D., Hysmith R.M., Boor P.J. Allylamine and β-aminopropionitrile-induced vascular injury: an in vivo and in vitro study. Toxicol. Appl. Pharmacol. 103:1990;288-302.
14. Lalich J.J., Paik W.C.W. Influence of cystine supplements on the incidence of aortic rupture in rats fed β-aminopropionitrile (32736). Proc. Soc. Exp. Biol. Med. 127:1968;543-546.
15. Lizcano J.M., Fernandez de Arriba A., Tipton K.F., Unzeta M. Inhibition of bovine lung semicarbazide-sensitive amine oxidase (SSAO) by some hydrazine derivatives. Biochem. Pharm. 52:1996;187-195.
16. Lyles G.A., Singh I. Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta. J. Pharm. Pharmacol. 37:1985;637-643.
17. Misra, P., Srivastava, S.K., Singhal, S.S., Awasthi, S., Awasthi, Y.C., Boor, P.J., 1995. Glutathione-S-transferase (GST) 8-8 is localized in smooth muscle cells of rat aorta and is induced in an experimental model of atherosclerosis. Toxicol. Appl. Pharmacol. 133, 27-33.
18. Nelson T.J., Boor P.J. Allylamine cardiotoxicity-IV. Metabolism to acrolein by cardiovascular tissues. Biochem. Pharmacol. 31:1982;509-514.
19. Page R.C., Benditt E.P. Molecular diseases of connective and vascular tissues II. Amine oxidase inhibition by the lathyrogen, β-aminopropionitrile. Biochemistry. 6:1967;1142-1148.
20. Ponseti I.V., Baird W.A. Scoliosis and dissecting aneurysm of the aorta in rats fed with lathyrus odoratus seeds. Am. J. Pathol. 28:1952;1059-1077.
21. Ramos K., Grossman S.L., Cox L.R. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors. Toxicol. Appl. Pharmacol. 95:1988;61-71.
22. Rao S.L.N., Malathi K., Sarma P.S. Lathyrism. World Rev. Nutr. Diet. 10:1969;214-238.
23. Rucker R.B., Goettlich-Riemann W. Properties of rabbit aorta amine oxidase. Proc. Soc. Exp. Biol. Med. 139:1972;286-289.
24. Simpson, C.F., Harms, R.H., 1969. Aortic dissecting aneurysms. Adv. Vet. Sci. Comp. Med. 13, 1-23.
25. Simpson C.F., Kling J.M., Palmer R.F. The use of propranolol for the protection of turkeys from the development of β-aminopropionitrile-induced aortic ruptures. Angiology. 19:1968;414-418.
26. Simpson C.F., Kling J.M., Robbins R.C., Harms R.H. β-aminopropionitrile-induced aortic ruptures in turkeys: inhibition by reserpine and enhancement by monoamine oxidase inhibitors. Toxicol. Appl. Pharmacol. 12:1968;48-59.
27. Trent M.B., Boor P.J. Vascular amine oxidase activities during synergistic vasculotoxicity. Toxicology. 89(1):1994;67-77.